CLOV (final idea)MID-TERM: 1hr classic bullish divergence, 4hr classic bullish divergence, daily hidden bullish divergence, bullish gartley harmonic pattern, support area being created, bullish candle signals. (not financial advice)
***My original idea here was wrong and I admit that, it's a combination of the market volatility this week and all the bagholders selling bounces. The sign of life today gives me more confidence, this just feels so similar to when I posted $FSR at $9 (went to $23) and when I posted $QS at $47 (went to $70).
CLOV34 trade ideas
$CLOVI dont how long its gonna take to get up to out TP but it sure will, Make sure you have a position open on this sleeping beast,I see it above $20 easy. For now it needs to close above $11.55 then the real move begins. Shorts sellers can't hold it down for too long. It has very high potential.
Please do ypour own DD.
Technically/Fundamentally its a sound stock to invest on.
Trade Safe.
$CLOV $14 Recovery PlayAfter being hit by a short-seller report published by Hindenburg Research on 02/04/2021, we saw $CLOV share price declining steadily up till the current value of $10.98 as of closing price Friday. Clover Health Investments Corp is a company that operates as a Medicare Advantage insurer in the United States by providing preferred provider organization and health maintenance organization health plans for Medicare-eligible consumers through its software platform - Clover Assistance. It is backed by Chamath Palihapitiya who has brought $CLOV public through a reverse merger with IPOC.
I believe at the current price that the share is trading at, $CLOV is an absolute bargain that is well-positioned for a recovery play with a great risk/reward ratio. I expect any dips into the $9.87 to $10.50 demand zone to be bought up rapidly by buyers who are looking to load up on $CLOV shares - which should translate to rapid bounce back of price off the demand zone. This held true on Thursday and Friday where we saw $CLOV temporarily dipping to $10.50, only to recover rapidly from that level.
I foresee $CLOV recovering steadily back to $14.10 once the negative sentiment created by the short-seller report starts fading away. The only reason why I am not putting my price target any higher than $14.10 for the time being is because I see the level between $14.13 and $17.22 to be an area of strong supply zone. However, if we are able to break above the supply zone, I believe that it is perfectly reasonable for $CLOV to be trading at shy of $20.00.
But for the time being, my target is $14.10. Please set SL based on your own risk tolerance.
This is not investment advice so please do your own due diligence!
Support this idea with likes and share your thoughts below.
$CLOVFinally seeing the first signs of potential bottom in Clover Health Investments Corp (CLOV). The has fallen hard over the past several weeks and looks ready for a rebound. CLOV's stock reacted very well again in the 10.5 price level support. Another bullish signal is coming from the MACD which is poised to cross above the signal line and this may spur further buy signals. Investors should consider getting long here.
CLOV will change trend? I think so.I think CLOV will begin an uptrend and to make an entry right now could possibly be a very good swing trading opportunity. A lot of interest is drawn to the stock as what I can see right now on different forums and platforms. Imo I don't want to miss this. Let's see how this ages:)!
Potential long set up on CLOVHere is hourly chart of CLOV. Clear bullish falling wedge and positive divergent on both RSI and PPO. It is in over sold territory on RSI as well. Breaking up front the wedge would be the first objective entrance. Back test of the wedge would be the second. Stop should be placed according to the upside target. There is no guarantee but it may be worth taking a shot.
Have a good trade,
T.
CLOV still at a discount. Looking at CLOV we are still trading at a discount. We are using the 100 sma line as support, and MACD is in the red still. Chammath responded to the short seller report by basically saying the company will speak for itself. He obviously is confident in the company and the short seller report is absolutely false. scooped up more shares today.
$CLOV Stick to the PlanTrue longs are staying patient, even with the volatile week we've experienced thus far.
$CLOV is attempting to make a presence within the healthcare industry, which is never an easy path. Their mission as a company will be very difficult to pursue, although a very lucrative one if executed adequately.
With a Biden Administration advocating health care for all in America, the push from various lawmakers in congress will help aid individuals gain access to companies like Clover, who are offering insurance at very little-to-none premiums, copays, and prescription drug prices.
I will be updating this post as I have entered a multi-week swing, which may turn into a long-term hold- depending on confirmation within the price action. GLTA!